Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. (2023)
Attributed to:
Investigation of the early growth response gene (Egr) 2 and 3 mediated regulatory programme in T cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00262-022-03319-w
PubMed Identifier: 36342511
Publication URI: http://europepmc.org/abstract/MED/36342511
Type: Journal Article/Review
Volume: 72
Parent Publication: Cancer immunology, immunotherapy : CII
Issue: 5
ISSN: 0340-7004